Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.071 | 0.7 |